Results 51 to 60 of about 507,096 (126)
Superstitions on Human Papillomavirus in Africa: A Scoping Review
Public Health Challenges, Volume 5, Issue 2, June 2026.Africa bears a high burden of HPV‐induced diseases; this scoping review explored how superstitions and cultural beliefs fuel vaccine hesitancy. There are widespread myths and opposition from cultural/religious leaders that drive HPV vaccine hesitancy; targeted and culturally sensitive campaigns/educations are essential to improve vaccine uptake and ...
Jimoh Amzat +6 more
wiley +1 more source
Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy
Allergy, Volume 81, Issue 6, Page 2156-2171, June 2026.This study investigates the allergenicity and immunogenicity profile of a novel plant‐derived Fel d 1 bioparticle (eBP). Fel d 1 eBP promotes immune tolerance by redirecting allergic Th2 responses toward Th1 and IL‐10–producing regulatory pathways, including Bregs.
Janice A. Layhadi +16 more
wiley +1 more source
, 2012 HPV är en grupp av över 100 olika virustyper varav 40 kan infektera könsorganen. Dessa virus orsakar den vanligaste sexuellt överförbara infektionen i Sverige och även i övriga världen.
Hadji, Siper
core +3 more sources
Human Vaccines & Immunotherapeutics, 2017 Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide.
Zhigang Zhang +3 more
doaj +1 more source
Advanced Functional Materials, Volume 36, Issue 33, 23 April 2026.We introduce a nucleic acid nanoparticle (NANP) platform designed to be rrecognized by the human innate immune system in a regulated manner. By changing chemical composition while maintaining constant architectural parameters, we identify key determinants of immunorecognition enabling the rational design of NANPs with tunable immune activation profiles
Martin Panigaj +21 more
wiley +1 more source
Biopharmaceuticals for Cancer Treatment: An Update
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath +6 more
wiley +1 more source
Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening
International Journal of Cancer, Volume 158, Issue 5, Page 1348-1360, 1 March 2026.What's New? While vaccination against high‐risk HPV infection, the primary cause of cervical malignancy, has demonstrated long‐term effectiveness in clinical trials, real‐life longitudinal data are lacking. Here, the authors present linked long‐term screening data on the effectiveness of bivalent HPV vaccination with a minimum follow‐up of 54 months ...
Timothy J. Palmer +6 more
wiley +1 more source
Acta Médica Costarricense, 2008 La infección por el virus del papiloma humano (VPH) es una enfermedad de transmisión sexual común. Alrededor del mundo millones de personas están infectadas y el resto de la población en general tiene un riesgo de contraer la infección superior al 50 ...
Wendy Chan Acón +3 more
doaj
Cancer Medicine, 2018 To add the growing literature on baseline of high‐risk human papillomavirus (HR‐HPV) genotype distribution in cervical intraepithelial neoplasia (CIN) before the widespread using of HPV vaccines in Chinese mainland and to improve risk stratification of ...
Yuli Wang +6 more
doaj +1 more source
Journal of Pharmacy & Pharmaceutical Sciences, 2015 Human Papillomaviruses (HPV) are a diverse group of small non-enveloped DNA viruses. Some HPVs are classified as low-risk as they are very rarely associated with neoplasia or cancer in the general population, and cause lenient warts.
Mohammad Nasir Uddin +2 more
doaj +1 more source